The global stoma/ostomy care market size reached US$ 3.5 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 4.7 Billion by 2032, exhibiting a growth rate (CAGR) of 3.3% during 2024-2032.
Report Attribute
|
Key Statistics
|
---|---|
Base Year
|
2023
|
Forecast Years
|
2024-2032
|
Historical Years
|
2018-2023
|
Market Size in 2023
|
US$ 3.5 Billion |
Market Forecast in 2032
|
US$ 4.7 Billion |
Market Growth Rate (2024-2032) | 3.3% |
A stoma, or bowel diversion, refers to an ostomy opening in the abdomen used to facilitate the removal of intestinal contents from the body. Stomas can be temporary or permanent and require special care for effective treatment. Some of the commonly used stoma/ostomy care devices include ostomy bags, seals, barrier rings, pouch covers, pouch closures and stoma caps. These devices are air- and water-tight and are attached to the abdominal wall to collect the waste material and can be disposed when required. They are primarily needed for the treatment of various chronic disorders, such as bowel, prostate or bladder cancer, Crohn’s disease and ulcerative colitis.
The increasing prevalence of inflammatory bowel disease (IBD), Crohn’s disease and colorectal and bladder cancer is one of the key factors driving the growth of the market. Furthermore, the rising geriatric population across the globe, which is more susceptible to such ailments, is providing a thrust to the market growth. In line with this, growing health consciousness and awareness regarding the available ostomy care products are also contributing to the market growth. Additionally, various technological advancements, such as the development of innovative ostomy care products that aid in minimizing odor and providing pH control to prevent skin infections, are acting as other growth-inducing factors. These products have human-centric designs that fit effectively and move with the body movements as the patient bends, due to which they are widely preferred by individuals and healthcare professionals. Other factors, including the implementation of campaigns by various government and not-for-profit organizations to promote effective ostomy care, along with significant improvements in the healthcare infrastructure, are anticipated to drive the market further.
IMARC Group provides an analysis of the key trends in each sub-segment of the global stoma/ostomy care market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on product, end user and surgery.
Breakup by Product:
Breakup by End User:
Breakup by Surgery:
Breakup by Region:
The competitive landscape of the industry has also been examined with some of the key players being 3M Co., Alcare Co. Ltd., B. Braun, BAO Health Medical Instrument Co. Ltd., Coloplast A/S, ConvaTec Group Plc, Flexicare Medical Limited, Hollister Incorporated, Marlen Manufacturing & Development Company, Nu-Hope Laboratories Inc., Schena Ostomy Technologies Inc. and Welland Medical Limited (Drive DeVilbiss Healthcare Ltd.).
Report Features | Details |
---|---|
Base Year of the Analysis | 2023 |
Historical Period | 2018-2023 |
Forecast Period | 2024-2032 |
Units | US$ Billion |
Segment Coverage | Product, End User, Surgery, Region |
Region Covered | Asia Pacific, Europe, North America, Latin America, Middle East and Africa |
Countries Covered | United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico |
Companies Covered | 3M Co., Alcare Co. Ltd., B. Braun, BAO Health Medical Instrument Co. Ltd., Coloplast A/S, ConvaTec Group Plc, Flexicare Medical Limited, Hollister Incorporated, Marlen Manufacturing & Development Company, Nu-Hope Laboratories Inc., Schena Ostomy Technologies Inc. and Welland Medical Limited (Drive DeVilbiss Healthcare Ltd.) |
Customization Scope | 10% Free Customization |
Report Price and Purchase Option | Single User License: US$ 3899 Five User License: US$ 4899 Corporate License: US$ 5899 |
Post-Sale Analyst Support | 10-12 Weeks |
Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |
The global stoma/ostomy care market was valued at US$ 3.5 Billion in 2023.
We expect the global stoma/ostomy care market to exhibit a CAGR of 3.3% during 2024-2032.
The sudden outbreak of the COVID-19 pandemic had led to postponement of elective treatment for bowel, prostate or bladder cancer, etc., to reduce the risk of the coronavirus infection upon hospital visits and interaction with medical equipment, thereby negatively impacting the global market for stoma/ostomy care.
The rising prevalence of Inflammatory Bowel Disease (IBD), Crohn’s disease, and colorectal and bladder cancer, along with the advent of innovative ostomy care products, that aid to minimize odor and provide pH control to prevent skin infections, is primarily driving the global stoma/ostomy care market.
Based on the product, the global stoma/ostomy care market can be categorized into ostomy bags and ostomy accessories. Currently, ostomy bags account for the majority of the total market share.
Based on the end user, the global stoma/ostomy care market has been segregated into home care settings and hospitals and specialty clinics, where home care settings currently hold the largest market share.
Based on the surgery, the global stoma/ostomy care market can be bifurcated into ileostomy, colostomy, and urostomy. Currently, colostomy exhibits a clear dominance in the market.
On a regional level, the market has been classified into North America, Asia-Pacific, Europe, Latin America, and Middle East and Africa, where Europe currently dominates the global market.
Some of the major players in the global stoma/ostomy care market include 3M Co., Alcare Co. Ltd., B. Braun, BAO Health Medical Instrument Co. Ltd., Coloplast A/S, ConvaTec Group Plc, Flexicare Medical Limited, Hollister Incorporated, Marlen Manufacturing & Development Company, Nu-Hope Laboratories Inc., Schena Ostomy Technologies Inc., and Welland Medical Limited (Drive DeVilbiss Healthcare Ltd.).